Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Cathie Wood’s trades often read like a quiet manifesto – what she buys signals confidence, what she trims hints at fading ...

CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...

Health system IT departments keep their employees happy by providing mission-driven environments focused on innovation, executives told Becker’s. In fact, 13 health systems were named among the 100 ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...

The adoption of the FAIR model was pivotal in transforming our cybersecurity strategy into a measurable, business-aligned ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

For years, many healthcare executives treated claim denials as a back-office irritation—a revenue problem to be delegated, ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...

New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, ...

The real issue is how to address overall cost. Haggling over Obamacare subsidies or what might replace them isn’t the ...